Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials

被引：3

作者：

Sachanas, Sotirios ^{[1
]}

Pangalis, Gerassimos A. ^{[1
]}

Fink, Anna-Maria ^{[2
,3
]}

Bahlo, Jasmin ^{[2
,3
]}

Fischer, Kirsten ^{[2
,3
]}

Levidou, Georgia ^{[3
,4
,5
]}

Kyrtsonis, Marie-Christine ^{[6
]}

Bartzi, Vassiliki ^{[7
]}

Vassilakopoulos, Theodoros P. ^{[8
]}

Kalpadakis, Christina ^{[9
]}

Koulieris, Efstathios ^{[1
]}

Moschogiannis, Maria ^{[1
]}

Yiakoumis, Xanthi ^{[1
]}

Tsirkinidis, Pantelis ^{[1
]}

Angelopoulou, Maria K. ^{[8
]}

Eichhorst, Barbara ^{[2
,3
]}

Hallek, Michael ^{[2
,3
]}

机构：

[1] Athens Med Ctr, Psychikon Branch, Dept Haematol, 1 Andersen Str, Athens 11525, Greece

[2] Univ Hosp Cologne, German CLL Study Grp, Dept Internal Med 1, Cologne, Germany

[3] Univ Hosp Cologne, German CLL Study Grp, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany

[4] Univ Athens, Pathol Dept, Athens, Greece

[5] Humanpathol GmbH, Pathol Dept, Erlangen, Germany

[6] Univ Athens, Laikon Gen Hosp, Dept Propedeut 1, Athens, Greece

[7] Gen Hosp Karditsa, Dept Haematol, Kardhitsa, Greece

[8] Univ Athens, Laikon Gen Hosp, Dept Haematol, Athens, Greece

[9] Univ Crete, Univ Hosp, Dept Haematol, Iraklion, Greece

来源：

ANTICANCER RESEARCH | 2019年 / 39卷 / 05期

关键词：

Small lymphocytic lymphoma; treatment; proliferation centers; PROLIFERATION CENTERS; CYCLOPHOSPHAMIDE; CLASSIFICATION; FLUDARABINE; RITUXIMAB;

D O I：

10.21873/anticanres.13382

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Only few studies have focused exclusively on patients with small lymphocytic lymphoma (SLL). Patients and Methods: In the present report, 103 SLL patients were analyzed from both, clinical trials of the German Chronic Lymphocytic Leukemia Study Group and Greek centers, and emphasis was placed on the therapeutic strategy. The impact of lymph node characteristics, such as the presence of proliferation centers (PCs) on response and survival was also assessed. Results: SLL patients included in clinical trials were treated mostly with fludarabine-based regimens while those in "reallife" were staged and treated mostly as patients with low-grade lymphomas. Our analysis showed a trend for better survival for patients with SLL without detectable PCs. Conclusion: Patients with SLL outside of clinical trials are usually treated as cases of lymphoma. In addition, this analysis supports published data regarding the adverse prognostic value of the presence of PCs in lymphoid nodes in SLL.

引用

页码：2591 / 2598

页数：8

共 50 条

[31] Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study
Woyach, Jennifer A.
Barr, Paul M.
Kipps, Thomas J.
Barrientos, Jacqueline C.
Ahn, Inhye E.
Ghia, Paolo
Girardi, Vincent
Hsu, Emily
Jermain, Mandy
Burger, Jan A.
CANCERS, 2023, 15 (02)
[32] Medical comorbidities in patients with chronic lymphocytic leukaemia treated with idelalisib: analysis of two large randomised clinical trials
Gordon, Max J.
Huang, Julie
Chan, Rebecca J.
Bhargava, Pankaj
Danilov, Alexey V.
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (04) : 720 - 728
[33] Second primary malignancies (SPM) in treated and untreated patients with chronic lymphocytic leukemia (CLL): an analysis of the registry of the German CLL Study Group (GCLLSG)
Fuerstenau, M.
Stumpf, T.
Fink, A. -M.
Robrecht, S.
Bahlo, J.
Maurer, C.
Linde, H.
Jacobasch, L.
Doerfel, S.
Lipke, J.
Aldaoud, A.
Fischer, K.
Eichhorst, B.
Hallek, M.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 19 - 19
[34] Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis
Wolowiec, Dariusz
Szymczyk, Agnieszka
Potoczek, Stanislaw
Krochmalczyk, Dorota
Zawirska, Daria
Piotrowska, Magdalena
Malenda, Agata
Soroka-Wojtaszko, Maria
Kopacz, Agnieszka
Wasik-Szczepanek, Ewa
Grabos-Michalak, Jolanta
Razny, Malgorzata
Wichary, Ryszard
Bramowicz-Jarosz, Bozena
Seweryn, Marek
Dlugosz-Danecka, Monika
Hus, Iwona
CHEMOTHERAPY, 2019, 64 (03) : 155 - 162
[35] B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: A clinical, morphologic, and biologic spectrum of similar disorders
Pangalis, GA
Angelopoulou, MK
Vassilakopoulos, TP
Siakantaris, MP
Kittas, C
SEMINARS IN HEMATOLOGY, 1999, 36 (02) : 104 - 114
[36] Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials
Teglgaard, Rebecca Svanberg
Marquart, Hanne Vibeke
Hartling, Hans Jakob
Bay, Jakob Thaning
da Cunha-Bang, Caspar
Brieghel, Christian
Faitova, Tereza
Enggaard, Lisbeth
Kater, Arnon P.
Levin, Mark-David
Kersting, Sabina
Ostrowski, Sisse Rye
Niemann, Carsten U.
CLINICAL CANCER RESEARCH, 2024, 30 (09) : 1959 - 1971
[37] Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)
Cramer, Paula
Isfort, Susanne
Bahlo, Jasmin
Stilgenbauer, Stephan
Doehner, Hartmut
Bergmann, Manuela
Stauch, Martina
Kneba, Michael
Lange, Elisabeth
Langerbeins, Petra
Pflug, Natali
Kovacs, Gabor
Goede, Valentin
Fink, Anna-Maria
Elter, Thomas
Fischer, Kirsten
Wendtner, Clemens-Martin
Hallek, Michael
Eichhorst, Barbara
HAEMATOLOGICA, 2015, 100 (11) : 1451 - 1459
[38] Second Primary Malignancies (SPMs) in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With the Combination of a Targeted Agent With an Antibody in 4 Phase 2 Trials of the German CLL Study Group (GCLLSG)
Goergen, Ellinor
von Tresckow, Julia
Giza, Adam
Robrecht, Sandra
Fink, Anna-Maria
Fischer, Kirsten
Al-Sawaf, Othman
Fuerstenau, Moritz
Simon, Florian
Kutsch, Nadine
Nieper, Pascal
Tausch, Eugen
Ritgen, Matthias
Boettcher, Sebastian
Kreuzer, Karl-Anton
Stilgenbauer, Stephan
Langerbeins, Petra
Eichhorst, Barbara
Hallek, Michael
Cramer, Paula
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S354 - S355
[39] Pooled Analysis of Cardiovascular Events from Clinical Trials Evaluating Acalabrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia (CLL)
Ferrajoli, Alessandra
Byrd, John C.
Ghia, Paolo
Sharman, Jeff P.
Hillmen, Peter
Stephens, Deborah M.
Sun, Clare
Jurczak, Wojciech
Pagel, John M.
Patel, Priti
Tao, Lin
Kuptsova-Clarkson, Nataliya
Moslehi, Javid
Furman, Richard R.
Brown, Jennifer R.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S323 - S323
[40] Pooled Analysis of Cardiovascular Events from Clinical Trials Evaluating Acalabrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia (CLL)
Brown, Jennifer R.
Byrd, John C.
Ghia, Paolo
Sharman, Jeff P.
Hillmen, Peter
Stephens, Deborah M.
Sun, Clare
Jurczak, Wojciech
Pagel, John M.
Ferrajoli, Alessandra
Patel, Priti
Baek, Marshall
Lezhava, Tamara
Kuptsova-Clarkson, Nataliya
Moslehi, Javid J.
Furman, Richard R.
BLOOD, 2020, 136

← 1 2 3 4 5 →